Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
2,859,697
-
Shares change
-
+168,482
-
Total reported value, excl. options
-
$308,836,202
-
Value change
-
+$18,210,431
-
Put/Call ratio
-
174%
-
Number of buys
-
44
-
Number of sells
-
-31
-
Price
-
$107.96
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q4 2014
88 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q4 2014.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,859,697 shares
.
Largest 10 shareholders include MORGAN STANLEY (569,538 shares), BANK OF AMERICA CORP /DE/ (410,136 shares), UBS Group AG (347,435 shares), GOLDMAN SACHS GROUP INC (154,419 shares), MATHER GROUP, INC. (127,061 shares), WELLS FARGO & COMPANY/MN (124,933 shares), Wharton Business Group, LLC (123,245 shares), LPL Financial LLC (105,717 shares), NIEMANN CAPITAL MANAGEMENT INC (91,941 shares), and Hoxton Financial, Inc. (86,741 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.